No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects

Research output: Contribution to journalReviewResearchpeer-review

Original languageEnglish
Article number170176
JournalPeptides
Volume125
ISSN0196-9781
DOIs
Publication statusPublished - 2020

    Research areas

  • Gastric inhibitory polypeptide, Glucose-dependent insulinotropic peptide, Tachyphylaxis, Desensitization, Insulin secretion, Hyperglycaemic clamp

ID: 245715375